Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-093482

Chief Financial Officer gave up 21,238 shares (to pay taxes)

  • Chief Financial Officer acquired 49,995 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roche Corleen M. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-06 Exercise or conversion : show line 1 in the form +49,995 49,995 D
2026-08-06 Shares withheld for taxes : show line 2 in the form −21,238 $6.21 $131,888 28,757 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-06 Exercise or conversion : show line 3 in the form Restricted Stock Units −49,995 100,005 D
Loading xslF345X06/tm2622610-1_4seq1.xml…